Hjem › Burkitts lymfom › Ohio › Toledo

Burkitts lymfom kliniske forsøg i Toledo, OH

4 studier for Burkitts lymfom søger deltagere på steder i og omkring Toledo (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

RekruttererFase 2

ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo

366 Days – 46 Years · Alle køn · Opdateret 2. okt. 2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

RekruttererFase 2

ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo

365 Days · Alle køn · Opdateret 25. sep. 2026 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

RekruttererFase 2

ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo

Alder 1 til 30 · Alle køn · Opdateret 1. sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RekruttererFase 3

ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo

365 Days – 25 Years · Alle køn · Opdateret 25. aug. 2026 · NCT03959085

Burkitts lymfom forsøg i andre byer

Andre studier i Toledo

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.